Skip to main content

Peer Review reports

From: A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis

Original Submission
24 Feb 2021 Submitted Original manuscript
23 Mar 2021 Reviewed Reviewer Report - Anthony Francis Markus
12 Jun 2021 Reviewed Reviewer Report - Paolo Boffano
15 Jun 2021 Reviewed Reviewer Report - Davide Gatti
30 Jun 2021 Author responded Author comments - Giuseppina Campisi
Resubmission - Version 2
30 Jun 2021 Submitted Manuscript version 2
1 Jul 2021 Reviewed Reviewer Report - Anthony Francis Markus
1 Jul 2021 Reviewed Reviewer Report - Paolo Boffano
1 Jul 2021 Reviewed Reviewer Report - Davide Gatti
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
1 Jul 2021 Editorially accepted
9 Jul 2021 Article published 10.1186/s13005-021-00280-4

You can find further information about peer review here.

Back to article page